| Dr Darwin Martin Koller, MD | |
|
910 Blackford St, Chattanooga, TN 37403-1405 | |
| (423) 778-6011 | |
| (865) 539-8008 |
| Full Name | Dr Darwin Martin Koller |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 910 Blackford St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568495638 | NPI | - | NPPES |
| 3333990 | Medicaid | TN | |
| 4110137 | Other | TN | BLUE CROSS |
| Entity Name | Southeastern Emergency Physicians Of Memphis Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437105277 PECOS PAC ID: 5395643209 Enrollment ID: O20050127000072 |
News Archive
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Zhang and co-principal investigators Sheng Ding, PhD, from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells. Their long-term goal is to restore visual function lost through diseases such as macular degeneration and retinitis pigmentosa.
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Previous studies have shown that breast cancer survivors who meet the current exercise recommendations (2.5 hours of moderate intensity physical activity per week) are at 25% lower risk for dying from breast cancer.
› Verified 3 days ago
| Entity Name | Tri-cities Regional Emergency Physicians, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063950046 PECOS PAC ID: 3678859477 Enrollment ID: O20170410002399 |
News Archive
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Zhang and co-principal investigators Sheng Ding, PhD, from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells. Their long-term goal is to restore visual function lost through diseases such as macular degeneration and retinitis pigmentosa.
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Previous studies have shown that breast cancer survivors who meet the current exercise recommendations (2.5 hours of moderate intensity physical activity per week) are at 25% lower risk for dying from breast cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darwin Martin Koller, MD Po Box 633819, Cincinnati, OH 45263-0001 Ph: () - | Dr Darwin Martin Koller, MD 910 Blackford St, Chattanooga, TN 37403-1405 Ph: (423) 778-6011 |
News Archive
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Zhang and co-principal investigators Sheng Ding, PhD, from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells. Their long-term goal is to restore visual function lost through diseases such as macular degeneration and retinitis pigmentosa.
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Previous studies have shown that breast cancer survivors who meet the current exercise recommendations (2.5 hours of moderate intensity physical activity per week) are at 25% lower risk for dying from breast cancer.
› Verified 3 days ago
Kathleen S Hunt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 910 Blackford St, Chattanooga, TN 37403 Phone: 423-778-6505 Fax: 423-778-3157 | |
Yolanda Spraggins, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1651 Gunbarrel Rd Ste 302, Chattanooga, TN 37421 Phone: 423-899-2904 Fax: 423-892-5058 | |
Jane S Catterton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 632 Morrison Springs Rd, Suite 300, Chattanooga, TN 37415 Phone: 423-877-4524 Fax: 423-875-5860 | |
Mr. Ricardo Federico Causo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6025 Lee Hwy, Ste. 447, Chattanooga, TN 37421 Phone: 423-490-1547 Fax: 423-490-1197 | |
Dr. Rachel A Nelson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7550 Goodwin Rd, Chattanooga, TN 37421 Phone: 423-894-3252 Fax: 423-894-2237 | |
Dr. William Woods Blake, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-6170 Fax: 423-778-6938 | |
Dr. Lisa Ann Lowery-smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-6170 Fax: 423-778-6938 |